Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.86
- Piotroski Score 7.00
- Grade Overweight
- Symbol (STR)
- Company Sitio Royalties Corp.
- Price $23.74
- Changes Percentage (1.19%)
- Change $0.28
- Day Low $23.52
- Day High $23.84
- Year High $25.95
Sitio Royalties Corp. operates as oil and gas mineral and royalty company. The company acquires oil-weighted rights in productive and the United States basins. It has approximately 140,000 net royalty acres through the consummation of over 180 acquisitions. The company was founded in 2016 and is headquartered in Denver, Colorado.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 11/19/2024
- Dividend Payable 11/27/2024
- Today N/A
- Next Earnings (Estimated) 02/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $28.00
- High Stock Price Target $33.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.38
- Trailing P/E Ratio -58.55
- Forward P/E Ratio -58.55
- P/E Growth -58.55
- Net Income $-15,536,000
Income Statement
Quarterly
Annual
Latest News of STR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Eat junk food when you're stressed? These 2 drinks can help your body...
New study reveals that flavanol-rich cocoa and green tea can protect the cardiovascular system against stress even after consuming fatty foods. Consuming high-flavanol cocoa improved blood flow, offer...
By New York Post | 16 hours ago -
Winter is coming - and so is my 50th birthday. It's time to eat all the pastries and grab all the joy | Emma Beddington
Embrace self-love and body positivity this winter. Give yourself a break, enjoy indulgent treats like Campari and pastries guilt-free. Focus on pleasure and joy, and embrace your "winter buddy" with a...
By The Guardian | 16 hours ago -
AHA 2024: Plozasiran demonstrates promising Phase III results in FCS adults
Plozasiran, a siRNA therapy, effectively reduces APOC3 levels to lower triglycerides in FCS patients....
By Yahoo! Finance | 16 hours ago
